Testosterone Enanthate is used to regulate normal growth and development of the male sex organs and for maintenance of secondary sex characteristics. These effects include the growth and maturation of the prostate, seminal vesicles, penis and scrotum in adolescent males and the development of male hair distribution such as beard, pubic, chest, and axillary hair, laryngeal enlargement, vocal cord thickening and alterations in body musculature and fat distribution in adults.
Our testosterone booster will cause retention of nitrogen, sodium, potassium, and phosphorous and decreased urinary excretion of calcium. Nitrogen balance is improved only when there is sufficient intake of calories and protein. If you are looking for other testosterone enanthate products, try our Gigatest which consist of Testosterone Enanthate and Testosterone Cypionate combined into 1 easy shot.
You can buy testosterone enanthate in 250ml or 500ml form. Bulk oil orders (250ml and 500ml) are packed in sterile aluminum canisters. you can also try our other injectable steroids that will fit your needs.
TEST-E (TESTOSTERONE ENANTHATE)
|EACH ML CONTAINS:|
|Grape Seed Oil||BP||q.s|
Testosterone Enanthate dosage and administration:
Half life 6 days
Adult dose (male): 250-1000mg ED, EOD, ETD or EFD by intramuscular injection
Adult dose (female): 25-100mg ED, EOD, ETD or EFD by intramuscular injection
Average Cycle Length: 4-12 weeks following an ED, EOD, ETD or EFD injection pattern
Anabolic #: 100
Androgenic #: 100
Bioavailability: Estimated at 100%
CAS Name: androst-4-en-3-one, 17-(3-cyclopentyl-1-oxopropoxy)-(17)
Visit our bodybuilding guide to read more of our articles about health and bodybuilding.
Hematologic: Suppression of clotting factors II, V, VII, and X, bleeding in patients on concomitant anticoagulant therapy, and polycythemia.
Androgens are contraindicated in men with carcinomas of the breast or with known or suspected carcinomas of the prostate and in women who are or may become pregnant.
Androgens are contraindicated in men with carcinomas of the breast or with known or suspected carcinomas of the prostate and in women who are or may become pregnant